San Rafael, CA, May 24, 2020 –(PR.com)– It is with profound sadness that AIM at Melanoma announces the death of its Founder and President, Valerie Guild, on May 21, 2020 from complications of ovarian cancer.
Archive | Of Interest
Nationally Regarded Melanoma Research Advocate and Founder, President of AIM at Melanoma, Val Guild, Dies
Posted in Melanoma News, Health Professionals, Patients, Latest News, Of Interest
Inherited genetic variations can alter progression of melanoma, indicates study
Sometimes cancer stays put, but often it metastasizes, spreading to new locations in the body. It has long been suspected that genetic mutations arising inside tumor cells drive this potentially devastating turn of events.
Posted in Melanoma News, Health Professionals, Of Interest
Skin Cancer Test Reduces Need for Surgery
SkylineDx in collaboration with the Mayo Clinic published yesterday its first study describing a diagnostic test that could reduce up to 42% of surgical interventions used to diagnose patients with melanoma (skin cancer).
Posted in Melanoma News, Health Professionals, Of Interest
Mouse models and patient data suggest potential biomarker for immunotherapy response in melanoma
CCR scientists have identified a molecular signature that could help clinicians assess whether someone with melanoma is likely to benefit from immunotherapy. The discovery, reported April 13, 2020, in Nature Medicine, was made using four genetically engineered mouse models of the deadly skin cancer.
Posted in Melanoma News, Health Professionals, Of Interest
